These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16955442)

  • 1. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
    Athey RJ; Walker RW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
    Kessels RP; Mimpen G; Melis R; Rikkert MG
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Executive function in Parkinson's disease].
    Kanazawa A; Mizuno Y; Narabayashi H
    Rinsho Shinkeigaku; 2001; 41(4-5):167-72. PubMed ID: 11676156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of TICS-M for the assessment of cognitive function in older adults.
    de Jager CA; Budge MM; Clarke R
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):318-24. PubMed ID: 12673608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1043-9. PubMed ID: 14618557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
    Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
    Sabbagh MN; Silverberg N; Bircea S; Majeed B; Samant S; Caviness JN; Reisberg B; Adler CH
    Parkinsonism Relat Disord; 2005 Aug; 11(5):311-5. PubMed ID: 15886042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
    Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
    J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.